Resveratrol in cardioprotection: a therapeutic promise of alternative medicine

Molecular Interventions
Dipak K Das, Nilanjana Maulik

Abstract

Resveratrol, a polyphenol phytoalexin, possesses diverse biochemical and physiological actions, including estrogenic, antiplatelet, and anti-inflammatory properties. Several recent studies determined the cardioprotective abilities of resveratrol. Both in experiments (acute) and in chronic models, resveratrol attenuates myocardial ischemic reperfusion injury, atherosclerosis, and reduces ventricular arrhythmias. It appears that resveratrol-mediated cardioprotection is achieved through the preconditioning effect (the best yet devised method of cardioprotection), rather than direct protection. Thus, resveratrol likely fulfills the definition of a pharmacological preconditioning compound and gives hope to the therapeutic promise of alternative medicine.

Citations

Dec 1, 2010·Cancer Chemotherapy and Pharmacology·Izet M KapetanovicDavid L McCormick
Sep 5, 2009·Genes & Nutrition·Istvan LekliDipak K Das
Feb 15, 2011·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Sara Soltanian, Maryam M Matin
Jun 5, 2010·The Proceedings of the Nutrition Society·Thea Magrone, Emilio Jirillo
Sep 24, 2009·Nutrition Research Reviews·Wendy J van der Spuy, Etheresia Pretorius
May 21, 2010·European Journal of Clinical Nutrition·V R Ramprasath, P J H Jones
Mar 8, 2013·International Journal of Impotence Research·S Dalaklioglu, G Ozbey
Dec 21, 2007·Antioxidants & Redox Signaling·Aldo BertelliDipak K Das
Dec 23, 2009·Cancer Biotherapy & Radiopharmaceuticals·Jingxuan WangFeng Qi
Dec 5, 2009·Cardiovascular Research·Narasimman GurusamyDipak K Das
Jul 2, 2009·Clinical and Experimental Pharmacology & Physiology·Dan-Li YangXiao-Hui Li
Jan 29, 2008·Photochemistry and Photobiology·Shannon Reagan-ShawNihal Ahmad
Apr 11, 2012·Photochemistry and Photobiology·Yuan-Hao LeeRandolph D Glickman
May 18, 2010·American Journal of Physiology. Heart and Circulatory Physiology·György Haskó, Pál Pacher
Mar 27, 2009·Journal of Translational Medicine·Hui-ling YangFrancesco M Marincola
Aug 18, 2010·Journal of Neuroinflammation·Xiaofeng LuYingying Le
Aug 23, 2008·Nutrition & Metabolism·Yukiko K NakamuraStanley T Omaye
Apr 29, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Yasar ColakFeruze Yilmaz Enc
Jan 29, 2010·Mediators of Inflammation·Katja LakotaSnezna Sodin-Semrl
Dec 24, 2009·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Kanti Bhooshan Pandey, Syed Ibrahim Rizvi
Apr 17, 2009·Canadian Journal of Physiology and Pharmacology·Suresh Varma Penumathsa, Nilanjana Maulik
Nov 16, 2010·Canadian Journal of Physiology and Pharmacology·Subhendu MukherjeeDipak K Das
Feb 24, 2016·International Journal of Molecular Sciences·Magdalena DziałoAnna Kulma
Nov 15, 2011·Journal of Pharmaceutical and Biomedical Analysis·Miguel MuzzioIzet M Kapetanovic
Nov 16, 2010·Neurobiology of Aging·Jae-Suk SeoSang-Youel Park
Jun 18, 2010·European Journal of Pharmacology·Jong Ro KimYoung Ran Kim
Oct 8, 2015·British Journal of Pharmacology·Makoto KuranoYutaka Yatomi
Mar 6, 2009·Cancer Letters·Shyamal K Goswami, Dipak K Das
Feb 7, 2015·Journal of Molecular and Cellular Cardiology·Anthony J DonatoLisa A Lesniewski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.